Among patients with normal IL-6 levels (Figure 4B), there was no significant difference in the percentage of severe COVID-19 between MAFLD and non-MAFLD patients (8.70% vs. 13.33%, p = 0.553). The gene discussed is IL6; the disease is COVID-19.